Background: There is increasing evidence that donor-specific anti-HLA antibodies (DSA) are associated with poor outcomes after cardiac transplantation in adults, but data are limited in children. The objective of this study was to examine the development and consequences of de novo DSA in pediatric recipients of heart transplants.
Methods: We analyzed 105 pediatric patients who received heart transplants at our center from January 2002 to December 2012.